Article

Vaccine Effectiveness of mRNA-1345 Against RSV-Associated Hospitalization and Medically Attended Acute Respiratory Illness Among US Veterans, 2025–2026

2026-04-17

Abstract excerpt

<h4>Background: </h4> Clinical trials showed mRNA-1345 (mRESVIA) was highly efficacious against RSV-associated lower respiratory tract disease in adults; real-world studies are critical to confirm vaccine impact on RSV-related healthcare usage. <h4>Methods:</h4> A retrospective matched test-negative case-control study used Veterans Health Administration electronic health records from the 2025–2026 respiratory seas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b868d934-c96c-5a14-bd0a-9894ec73836d
DOI: 10.20944/preprints202604.1261.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Vaccine Effectiveness of mRNA-1345 Against RSV-Associated Hospitalization and Medically Attended Acute Respiratory Illness Among US Veterans, 2025–2026DOI 10.20944/preprints202604.1261.v1Read

Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity Read

Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity Read

Comparative effectiveness of mRNA-1273 versus protein-based NVX-CoV2705 vaccination on COVID-19-related outcomes among US insured adults during 2024–2025: a retrospective matched cohort studySemantic proximity Read

Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort StudySemantic proximity Read

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United StatesSemantic proximity Read

Modeling the Anticipated Public Health Benefits of the Next-Generation COVID-19 mRNA-1283 vaccine: An Interim U.S. Population-Level Impact AssessmentSemantic proximity Read

Bivalent RSVpreF effectiveness against RSV-related lower respiratory tract disease hospitalization and ED visits across three RSV SeasonsSemantic proximity Read

Shared Clinical and Immunologic Features of mRNA Vaccines: Preliminary Results from a Comparative Clinical StudySemantic proximity Read

Modeling the Cost-Effectiveness of the Next-Generation COVID-19 mRNA-1283 vaccine in the United StatesSemantic proximity Read

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infectionSemantic proximity Read

Effectiveness of mRNA COVID-19 Booster Vaccines against Omicron and Delta Variants among US VeteransSemantic proximity Read

Design and preclinical assessment of mRNA-1345 prefusion F glycoprotein-encoding mRNA vaccine for respiratory syncytial virusSemantic proximity Read